Physical Activity and Sedentary Behavior During Pregnancy
Care Pathway Organization in Order to Increase Physical Activity Levels and Limit Sedentary Behavior During Pregnancy: a Randomized Controlled Trial
University Hospital, Clermont-Ferrand
630 participants
Sep 10, 2024
INTERVENTIONAL
Conditions
Summary
Our main objective is to evaluate the intervention that best enables women's adherence to physical activity (PA). Our hypothesis is that identifying types of interventions suitable for pregnant women (in-person PA sessions, videoconferences or mixed format) could help improve their PA level and simultaneously reduce their sedentary behavior (SB).
Eligibility
Inclusion Criteria24
- Pregnant women of more of 18 years and who are being monitored for pregnancy in the Clermont-Ferrand metropolitan area,
- Planned to give birth in a maternity unit localized in Clermont-Ferrand metropolitan area (CHU Estaing or Clinique de la Chataigneraie),
- Agreeing to be randomized, to follow the physical activity program offered in the Clermont-Ferrand metropolitan area, and to follow up as part of the study,
- Able to give informed consent to participate in the research,
- Affiliated to a social security scheme
- And between 14+0d and 21+6d weeks of gestation.
- Women under guardianship, curators, deprived of liberty or under court protection,
- With a history of recurrent miscarriage,
- Presenting a multiple pregnancy,
- Hemoglobinemia \<9g/dL or symptomatic anemia,
- Presenting eating disorders or a BMI ≤ 18.5 or a BMI ≥ 40,
- With orthopedic limitations,
- Presenting cardiovascular or pulmonary disease,
- Uncontrolled thyroid disease,
- Presenting a high level of smoking,
- With significant health problems,
- Premature rupture of membranes,
- Premature labor during this pregnancy or a history of at least 2 premature births,
- Persistent vaginal bleeding,
- Cervical incompetence,
- Evidence of intrauterine growth restriction,
- Uncontrolled epilepsy,
- Diabetes (previous or gestational, diagnosed in the 1st trimester) or chronic hypertension,
- Or having a planned home birth.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Group B women will have access to a weekly program of 3 face-to-face PA sessions. The face-to-face sessions will be offered at one or more locations in the Clermont-Ferrand area, depending on the number of groups taking part. They will also be offered at one or more times depending on the number of groups. Locations and times will be specified on the online booking software. Women can only register for 3 sessions per week.
Women in Group C will have access to a weekly program of 3 PA sessions via interactive videoconferencing. These sessions will have the same format as the face-to-face sessions with visualization of the APA professional, visualization of the participants (who can also choose to be masked). The PA professional will also see the participants, so he or she can correct positions and give individualized advice at any time. Schedules will be specified on the online booking software with the videoconference link. Women can only register for 3 sessions per week.
Women in Group D will have access to a weekly program of 3 mixed-format PA sessions, with 2 interactive distance learning sessions and 1 in-person session. The in-person sessions will be offered at one or more locations in the Clermont-Ferrand area, depending on the number of groups taking part. Locations and times will be specified on the online booking software. Women can only register for 1 face-to-face session per week. The other 2 sessions will be offered via interactive videoconferencing. These sessions will have the same format as the in-person sessions, with visualization of the APA professional, visualization of the participants. The APA professional will also see the participants, so he or she can correct positions and give individualized advice at any time. Schedules will be specified on the online booking software with the videoconference link. Women can only register for 2 videoconference's sessions per week.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06585085